Prelude Therapeutics Inc - Common Stock, par value $0.0001 per share (PRLD)
CUSIP: 74065P101
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 51,297,696
- Total 13F shares
- 33,917,161
- Share change
- -309,867
- Total reported value
- $129,220,239
- Put/Call ratio
- 25%
- Price per share
- $3.81
- Number of holders
- 59
- Value change
- -$1,353,555
- Number of buys
- 23
- Number of sells
- 28
Quarterly Holders Quick Answers
What is CUSIP 74065P101?
CUSIP 74065P101 identifies PRLD - Prelude Therapeutics Inc - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 74065P101:
Top shareholders of PRLD - Prelude Therapeutics Inc - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
3/4/5
|
Company · Director, 10%+ Owner |
21%
|
10,909,256
|
$51,709,873 | — | 31 Mar 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
20%
|
10,123,824
|
$47,986,926 | — | 31 Mar 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
8.1%
|
4,133,000
|
$19,590,420 | — | 31 Mar 2024 | |
| Boxer Capital, LLC |
13F
|
Company |
5%
|
2,568,287
|
$12,173,680 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.1%
|
1,097,474
|
$5,202,026 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
2%
|
1,016,999
|
$4,820,576 | — | 31 Mar 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.8%
|
941,971
|
$4,466,000 | — | 31 Mar 2024 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.99%
|
508,149
|
$2,408,626 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.7%
|
361,632
|
$1,714,342 | — | 31 Mar 2024 | |
| Sio Capital Management, LLC |
13F
|
Company |
0.62%
|
320,394
|
$1,518,668 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.58%
|
296,205
|
$1,404,010 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.48%
|
244,800
|
$1,160,000 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.41%
|
211,441
|
$1,002,230 | — | 31 Mar 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.31%
|
160,652
|
$761,490 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.25%
|
127,370
|
$603,734 | — | 31 Mar 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.24%
|
123,600
|
$585,864 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.24%
|
122,147
|
$578,977 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.2%
|
101,850
|
$482,769 | — | 31 Mar 2024 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.14%
|
72,262
|
$342,522 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.14%
|
70,200
|
$332,748 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.13%
|
67,427
|
$319,604 | — | 31 Mar 2024 | |
| EXCHANGE TRADED CONCEPTS, LLC |
13F
|
Company |
0.12%
|
63,887
|
$302,824 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.12%
|
60,597
|
$287,230 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.08%
|
40,068
|
$189,922 | — | 31 Mar 2024 | |
| Laurent Chardonnet |
3/4/5
|
Chief Financial Officer |
—
mixed-class rows
|
192,165
mixed-class rows
|
$158,962 | — | 01 Mar 2024 | |
| Cerity Partners LLC |
13F
|
Company |
0.06%
|
32,500
|
$154,050 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.06%
|
32,264
|
$152,931 | — | 31 Mar 2024 | |
| Pale Fire Capital SE |
13F
|
Company |
0.06%
|
31,481
|
$149,220 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.06%
|
29,795
|
$141,228 | — | 31 Mar 2024 | |
| KENNEDY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.05%
|
25,035
|
$118,666 | — | 31 Mar 2024 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.05%
|
24,905
|
$118,050 | — | 31 Mar 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.04%
|
22,110
|
$104,000 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.04%
|
21,166
|
$100,318 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.04%
|
20,387
|
$96,634 | — | 31 Mar 2024 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.04%
|
20,122
|
$95,378 | — | 31 Mar 2024 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.04%
|
20,066
|
$95,113 | — | 31 Mar 2024 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.04%
|
19,600
|
$92,904 | — | 31 Mar 2024 | |
| ZACKS INVESTMENT MANAGEMENT |
13F
|
Company |
0.04%
|
18,457
|
$87,484 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.03%
|
16,797
|
$79,618 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.03%
|
16,388
|
$77,679 | — | 31 Mar 2024 | |
| Walleye Capital LLC |
13F
|
Company |
0.03%
|
16,380
|
$77,641 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.03%
|
15,655
|
$74,205 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.03%
|
14,305
|
$67,805 | — | 31 Mar 2024 | |
| PRELUDE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
13,846
|
$65,630 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
0.02%
|
11,550
|
$54,747 | — | 31 Mar 2024 | |
| Amundi |
13F
|
Individual |
0.03%
|
15,130
|
$52,047 | — | 31 Mar 2024 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0.01%
|
7,333
|
$34,758 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.01%
|
6,247
|
$29,611 | — | 31 Mar 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.01%
|
5,274
|
$24,999 | — | 31 Mar 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
3,347
|
$15,864 | — | 31 Mar 2024 |
Institutional Holders of Prelude Therapeutics Inc - Common Stock, par value $0.0001 per share (PRLD) as of Q2 2024
As of 30 Jun 2024,
Prelude Therapeutics Inc - Common Stock, par value $0.0001 per share (PRLD) was held by
59 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
33,917,161 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, BAKER BROS. ADVISORS LP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Boxer Capital, LLC, BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, MASSACHUSETTS FINANCIAL SERVICES CO /MA/, GEODE CAPITAL MANAGEMENT, LLC, and Sio Capital Management, LLC.
This page lists
59
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
56
Q2 2024 holders
59
Holder diff
3
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.